Box 2.

Criteria for appraising the quality of prevalence studies

Was the case definition clear? Was case ascertainment complete? Were details of nonresponders or those not tested clear? Was the group studied representative of your patient? Did prevalence estimates include confidence intervals and take into account the possibility of different disease rates in the nonresponders?